Literature DB >> 21957283

Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

José González-Santamaría1, Michela Campagna, María Angel García, Laura Marcos-Villar, Dolores González, Pedro Gallego, Fernando Lopitz-Otsoa, Susana Guerra, Manuel S Rodríguez, Mariano Esteban, Carmen Rivas.   

Abstract

The vaccinia virus (VACV) E3 protein is essential for virulence and has antiapoptotic activity and the ability to impair the host innate immune response. Here we demonstrate that E3 interacts with SUMO1 through a small ubiquitin-like modifier (SUMO)-interacting motif (SIM). SIM integrity is required for maintaining the stability of the viral protein and for the covalent conjugation of E3 to SUMO1 or SUMO2, a modification that has a negative effect on the E3 transcriptional transactivation of the p53-upregulated modulator of apoptosis (PUMA) and APAF-1 genes. We also demonstrate that E3 is ubiquitinated, a modification that does not destabilize the wild-type protein but triggers the degradation of an E3-ΔSIM mutant. This report constitutes the first demonstration of the important roles that both SUMO and ubiquitin play in the regulation of the VACV protein E3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957283      PMCID: PMC3233166          DOI: 10.1128/JVI.05628-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Polyubiquitin chains: polymeric protein signals.

Authors:  Cecile M Pickart; David Fushman
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

2.  The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories.

Authors:  Bianca T Hovey Nerenberg; John Taylor; Eric Bartee; Kristine Gouveia; Michele Barry; Klaus Früh
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  System-wide changes to SUMO modifications in response to heat shock.

Authors:  Filip Golebiowski; Ivan Matic; Michael H Tatham; Christian Cole; Yili Yin; Akihiro Nakamura; Jürgen Cox; Geoffrey J Barton; Matthias Mann; Ronald T Hay
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

4.  Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.

Authors:  Henri A Blomster; Ville Hietakangas; Jianmin Wu; Petri Kouvonen; Sampsa Hautaniemi; Lea Sistonen
Journal:  Mol Cell Proteomics       Date:  2009-02-24       Impact factor: 5.911

5.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

6.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation.

Authors:  T V Sharp; F Moonan; A Romashko; B Joshi; G N Barber; R Jagus
Journal:  Virology       Date:  1998-10-25       Impact factor: 3.616

7.  A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein.

Authors:  R D Everett; M Meredith; A Orr; A Cross; M Kathoria; J Parkinson
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

8.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.

Authors:  C Rivas; J Gil; Z Mĕlková; M Esteban; M Díaz-Guerra
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

9.  Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.

Authors:  Holger Ludwig; Jörg Mages; Caroline Staib; Michael H Lehmann; Roland Lang; Gerd Sutter
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 10.  Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection.

Authors:  Marisa K Isaacson; Hidde L Ploegh
Journal:  Cell Host Microbe       Date:  2009-06-18       Impact factor: 21.023

View more
  19 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

3.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.

Authors:  Xiaoxi Lin; Rui Sun; Fang Zhang; Yuan Gao; Lianghua Bin; Ke Lan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

4.  SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.

Authors:  Yan Liu; Zhenhua Zheng; Bo Shu; Jin Meng; Yuan Zhang; Caishang Zheng; Xianliang Ke; Peng Gong; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

5.  Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus.

Authors:  Ya-Chun Yang; Yushi Yoshikai; Shih-Wei Hsu; Hisato Saitoh; Li-Kwan Chang
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

6.  The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.

Authors:  Elodie Blondel-Tepaz; Marie Leverve; Badr Sokrat; Justine S Paradis; Milena Kosic; Kusumika Saha; Cédric Auffray; Evelyne Lima-Fernandes; Alessia Zamborlini; Anne Poupon; Louis Gaboury; Jane Findlay; George S Baillie; Hervé Enslen; Michel Bouvier; Stéphane Angers; Stefano Marullo; Mark G H Scott
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

7.  Regulation of the Ebola Virus VP24 Protein by SUMO.

Authors:  Santiago Vidal; Ahmed El Motiam; Rocío Seoane; Viktorija Preitakaite; Yanis Hichem Bouzaher; Sergio Gómez-Medina; Carmen San Martín; Dolores Rodríguez; María Teresa Rejas; Maite Baz-Martínez; Rosa Barrio; James D Sutherland; Manuel S Rodríguez; César Muñoz-Fontela; Carmen Rivas
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

8.  The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.

Authors:  Stacy D White; Bertram L Jacobs
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

9.  Functional analysis of the short isoform of orf virus protein OV20.0.

Authors:  Yeu-Yang Tseng; Fong-Yuan Lin; Sun-Fang Cheng; David Tscharke; Songkhla Chulakasian; Chia-Chi Chou; Ya-Fen Liu; Wei-Shan Chang; Min-Liang Wong; Wei-Li Hsu
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

10.  Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO).

Authors:  Carlos F de la Cruz-Herrera; Michela Campagna; Maria A García; Laura Marcos-Villar; Valerie Lang; Maite Baz-Martínez; Sylvia Gutiérrez; Anxo Vidal; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.